CNS pipeline · person
Charles Duncan, PhD
Director of Vanda Pharmaceuticals, appointed in April 2026. He is President of Sulci Advisors, a life-sciences advisory firm he founded in 2025, and spent nearly three decades as a biotechnology equity research analyst, most recently as Managing Director and Senior Biotechnology Analyst at Cantor Fitzgerald; he holds a PhD in pharmaceutical sciences (neuropharmacology) from the University of Colorado-Boulder.
- 1 company
Current roles
- Vanda Pharmaceuticals Inc.Director · Board
Appears with
People sharing a company with Charles.
- Anne Sempowski Ward · Vanda Pharmaceuticals Inc.
- Christos Polymeropoulos · Vanda Pharmaceuticals Inc.
- Daniel McGuire · Vanda Pharmaceuticals Inc.
- Gunther Birznieks · Vanda Pharmaceuticals Inc.
- Joakim Wijkstrom · Vanda Pharmaceuticals Inc.
- Kevin Moran · Vanda Pharmaceuticals Inc.
- Mihael H. Polymeropoulos · Vanda Pharmaceuticals Inc.
- Phaedra S. Chrousos · Vanda Pharmaceuticals Inc.
- Richard W. Dugan · Vanda Pharmaceuticals Inc.
- Scott Howell · Vanda Pharmaceuticals Inc.
- Stephen Ray Mitchell · Vanda Pharmaceuticals Inc.
- Tage Honoré · Vanda Pharmaceuticals Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.